Research and apply personalized engagement strategies to improve health outcomes
TRUSTED BY LEADING RESEARCH AND CLINICAL ORGANIZATIONS
Do more with Way to Health
Mix and match modules from Way To Health's suite to personalize interventions
Choose from a variety of communication mediums tailored to a patient's preference. Include peers or support partners.
Capture data from remote monitoring devices simply and seamlessly, enabling scalable, integrated and personalized initiatives.
Use a purpose built solution to design and deploy behavioral change and interventional (automated hovering) research.
Leverage a library of various behavioral economics tools e.g. social and financial incentives to nudge or change behavior.
Allow patients to earn points, level up, use lifelines and more. Combine with peers or support partners and see higher engagement.
Configure the flexible rules engine quickly. Trigger actions by time or data captured from patients via messages, devices or EHR data.
CASE STUDY SPOTLIGHTS
Cirrhosis & Transplants
|Reduce 30-day readmissions for cirrhosis and post-transplant patients by remotely monitoring weight, mental function, medication adherence and temperature|
|Reduced 7-day readmissions by 43%|
|Reduced preventable readmits by 75%|
|Reduce 7-day readmissions for hypertension among postpartum women and creating a national leadership model to meet ACOG guidelines|
|Increased guideline adherence by 80%|
|Reduced 7 day readmission by 80%|
|Effectiveness of daily financial incentives on glucose monitoring adherence and glycemic control in adolescents & young adults with type 1 diabetes.|
|Effectiveness of financial incentives|
|Improved glucose monitoring by 62%|
|Gamification designed to leverage insights from behavioral economics offers a promising approach to improve daily health behaviors at low cost|
|Increased activity achievement by 50%|
|Post study activity increased by 27%|
Cardiovascular Disease Management
|Shared physician and patient incentives are more effective in reducing levels of low-density lipoprotein cholesterol (LDL-C) among patients with high CVD risk.|
|Reduced LDL-C by 33%|
|Aligned patient and provider incentives|